The Molecular & Cell Biology & Genetics (MCBG) program is an interdisciplinary graduate program recognizing the need for highly trained scientists conversant across various disciplines.
The program provides a broad education-training program for graduate students interested in biomedical problems that cross disciplinary boundaries and offers the opportunity for students to choose from approximately 60 faculty in 10 different departments/centers to pursue their research interests. This program offers both MS and PhD degrees and focuses on the study of the structure, function and makeup of biologically important molecules within the context of the living cells. Our curriculum and research activities are tailored to students’ needs and interests. See our areas of research interest.
Our faculty are at the forefront of new advances in the biomedical sciences and new developments in techniques for understanding the genetic and molecular basis of developmental pathways and disease states such as cancer, aging, AIDS, malaria and neurological disorders. Consequently, students can pursue a diverse variety of projects that range from the design and development of new therapeutic treatment strategies to the characterization of the molecular mechanisms that underlie various cellular processes and diseases. This intensive and research-oriented program provides students with opportunities to perform cutting edge biomedical research employing multidisciplinary strategies. Learn more about our faculty.
Learn more about the curriculum for the Molecular & Cell Biology & Genetics program.
Recent Molecular & Cell Biology & Genetics program graduates are at:
Children’s Hospital of Pennsylvania
Drexel University College of Medicine
Fox Chase Cancer Center
Lankenau Institute for Medical Research
Massachusetts General Hospital/Harvard Medical School
New York Presbyterian Hospital/Weil Cornell Medical Center
New York University Langone Medical Center
Public Health Research Institute/Rutgers New Jersey Medical School
Scripps Research Institute
Temple University School of Medicine
Thomas Jefferson University
University of North Carolina
University of North Dakota
University of Pennsylvania School of Veterinary Medicine
Biotech and Pharmaceutical Companies
Accu Reference Medical Lab
Eurofins Lancaster Laboratories Environmental, LLC
Janssen Pharmaceutical Companies of Johnson & Johnson
Merck & Co.
ONCOVEDA Cancer Research Center
Abington Jefferson Hospital
News and Announcements
Alyssa Duffy will start her PhD studies in Cancer Biology Program at Emory University. Alyssa has been conducting her MS research in the laboratory of Dr. Eishi Noguchi, Department of Biochemistry & Molecular Biology.
Baicheng Lin will start his PhD studies in Biomedical Sciences Program at Medical University of South Carolina. Baicheng has been conducting his MS research in the laboratory of Dr. Eishi Noguchi, Department of Biochemistry & Molecular Biology.
Michael Owens will start his PhD studies in Biochemistry & Molecular Biophysics Program at University of Pennsylvania School of Medicine. Michael has been conducting his MS research in the laboratory of Dr. Srinivas Somarowthu, Department of Biochemistry & Molecular Biology.
Shridhar Sanghvi has successfully transitioned into the MCBG PhD Program at Drexel University College of Medicine. Shridhar has been conducting his MS research in the laboratory of Dr. Harpreet Singh, Department of Pharmacology & Physiology.
Maya Rao, PhD, an MCBG graduate, recently published "Interaction between the AAA+ ATPase p97 and its cofactor ataxin3 in health and disease: Nucleotide-induced conformational changes regulate cofactor binding" in the November issue of the Journal of Biological Chemistry. Maya's artwork also appeared on the cover of the issue. Read more.
Kelly Whelan, PhD, an MCBG graduate, has accepted the position of assistant professor of pathology and laboratory Medicine at Temple University School of Medicine. Kelly did her dissertation work under the guidance of Dr. Mauricio Reginato, Department of Biochemistry & Molecular Biology.
Niyant Shah, MS, an MCBG graduate, currently holds the role of senior scientist at GlaxoSmithKline, where he is part of a team developing novel small molecule inhibitors of epigenetic targets to treat cancer. Niyant did his MS work under the guidance of Dr. Eishi Noguchi, Department of Biochemistry & Molecular Biology.
Discovery Day 2017 Winners
- Zachary Bacigalupa (Mentor: Mauricio Reginato): Outstanding Platform Presentation (2nd place)
- Andrew Matamoros (Mentor: Peter Baas): Outstanding Platform Presentation (Honorable mention)
- Kelly Donovan (Mentor: Jane Clifford): Outstanding Senior Graduate Student Poster (1st place)
- Jasmine Peake (Mentor: Eishi Noguchi): Outstanding Senior Graduate Student Poster (2nd place)
- Micheal Owens (Mentor: Srinivas Somarowthu): Outstanding Junior Graduate Student Poster (3rd place)
See a complete listing of this year's Discovery Day winners.